Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer
Crossref DOI link: https://doi.org/10.1007/s12282-017-0822-8
Published Online: 2017-11-28
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Inoue, Hiroaki
Horii, Rie http://orcid.org/0000-0002-4227-2739
Ito, Yoshinori
Iwase, Takuji
Ohno, Shinji
Akiyama, Futoshi
License valid from 2017-11-28